Kazia Therapeutics Limited - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record

Representative image of a large-scale copper mining operation in Chile, reflecting investor focus on Antofagasta PLC shares, Q1 2026 production stability, and the Centinela Second Concentrator growth story.

Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule

Shubman Gill’s 86 steers Gujarat Titans past Kolkata Knight Riders in IPL 2026

Kizik debuts Freedom Run, betting step-in technology can break into performance running

Kizik launches Freedom Run as it pushes hands-free footwear into the performance running market

Representative image of oncology drug discovery and epigenetic cancer research, illustrating the scientific backdrop to Kazia Therapeutics’ SETDB1 platform expansion and KZIA stock story.

Read More

Pharma Industry News

Kazia Therapeutics (NASDAQ: KZIA) bets on SETDB1 to widen oncology pipeline beyond paxalisib

Kazia Therapeutics has licensed a SETDB1 oncology platform from QIMR Berghofer. Read why the move could reshape KZIA’s pipeline strategy.

April 14, 2026

web analytics